EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations

Gabriel Gomis, Pedro Berraondo, Claudia Herrero, Carlos Luri-Rey, Ignacio Melero

Trends in Immunology · 2026-11 · 47 (11) · 966-978

DOI: 10.1016/j.it.2026.06.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026-11. Verfasst von Gabriel Gomis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain. Hauptthemen laut MEDLINE: Cross-Priming, Immunoconjugates, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross-PrimingImmunoconjugatesNeoplasmsImmunotherapyDendritic CellsHumansAnimalsAntigens, NeoplasmAntibodies, Monoclonal

Stichwörter der Autor:innen

antibody–drug conjugatecDC1cross-presentationcross-primingimmunogenic cell death

Substanzen

ImmunoconjugatesAntigens, NeoplasmAntibodies, Monoclonal

Autor:innen und Institutionen

  • Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.
  • Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Inve…
  • Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), Madrid, Spain.

Zitieren

APA

Gomis, G., Berraondo, P., Herrero, C., Luri-Rey, C., & Melero, I. (2026). Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations. Trends in Immunology, 47(11), 966-978. https://doi.org/10.1016/j.it.2026.06.003

Vancouver

Gomis G, Berraondo P, Herrero C, Luri-Rey C, Melero I. Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations. Trends in Immunology. 2026;47(11):966-978. doi:10.1016/j.it.2026.06.003

BibTeX
@article{Gomis2026,
  author = {Gomis, Gabriel and Berraondo, Pedro and Herrero, Claudia and Luri-Rey, Carlos and Melero, Ignacio},
  title = {Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations},
  journal = {Trends in Immunology},
  year = {2026},
  volume = {47},
  number = {11},
  pages = {966--978},
  doi = {10.1016/j.it.2026.06.003}
}
Kostenlos starten →